PrEP Watch is a clearinghouse for PrEP data, research, cost, access, implementation and advocacy efforts across the globe.

Learn more about PrEP

Where do you fit on the map?

Countries are at varying stages of introducing daily oral tenofovir-based PrEP, which is recommended by WHO as a prevention option for people at substantial risk of HIV. Some countries have national programs; others have smaller-scale programs; others aren’t offering PrEP at all.

In this regularly updated map, yellow countries have some form of PrEP programming; blue countries do not. Want to take the next step in expanding access to PrEP? Check out PrEP Planning A-Z.

PrEP Planning A–Z

This step-by-step framework for scaling up PrEP outlines what's involved for introducing oral PrEP and provides links to tools and resources.

Resources You Can Use

  • Global PrEP Tracker

    This sortable database includes quarterly updates on national programs delivering oral PrEP, country guidelines and targets, drug registration status and more.

  • Lessons from the Field

    As oral PrEP rolls out globally, implementers are facing and overcoming real-world obstacles. Lessons from the Field brings you these stories. Come here to learn from others, sharpen insights and find useful resources.

  • Oral PrEP Enrollment Snapshot

    An analysis of global PrEP uptake, based on quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and data from manufacturers and government agencies.

News Spotlight

  • Who Endorses Event-Driven PrEP for Gay Men

    July 24, 2019

    The World Health Organization (WHO) has updated its recommendation for pre-exposure prophylaxis (PrEP) to include event-driven PrEP taken before and after sex – also called on-demand PrEP or the 2+1+1 schedule – as an HIV prevention option for men who have sex with men.

    Read more

  • Expert Panel Recommends PrEP for HIV Prevention

    June 11, 2019

    The US Preventive Services Task Force issued a recommendation today calling on health care providers to offer pre-exposure prophylaxis, or PrEP, to men and women at high risk of acquiring HIV. The Affordable Care Act requires private insurers to cover preventive services recommended by the USPSTF with an “A” or “B” rating.

    Read more